Skip to main navigation Skip to search Skip to main content

Development of recalcitrant cutaneous eruptions in patients with relapsed/refractory Hodgkin's lymphoma undergoing treatment with camidanlumab tesirine

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
Pages (from-to)e890-e893
JournalJournal of the European Academy of Dermatology and Venereology
Volume37
Issue number7
DOIs
StatePublished - Jul 2023

Cite this